Tagrisso, a drug used to treat cancer patients, has been approved to be fast-tracked to patients in the people's republic via a new system created to quickly push through western medicines into China. Made by British-Swedish pharmaceutical company Astra Zeneca, the drug treats a particular mutation of lung cancer that affects 40% of Asian patients, a higher proportion than among Caucasian sufferers.
Tagrisso, a drug used to treat cancer patients, has been approved to be fast-tracked to patients in China via a new system created to quickly push through western medicines into the people's republic. Made by British-Swedish pharmaceutical company Astra Zeneca, the drug treats a particular mutation of lung cancer that affects 40% of Asian patients, a higher proportion than among Caucasian sufferers.